フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
UK claimants Wednesday announced legal action against US pharmaceutical and cosmetics firm Johnson & Johnson, allegin ...
Johnson & Johnson on Tuesday posted weaker earnings in the first quarter despite growing sales, as research and devel ...
Johnson & Johnson on Wednesday announced the completion of its USD600 million acquisition of heart failure treatment ...
Johnson & Johnson on Tuesday announced an acquisition for its MedTech division, as well as a US approval for its lung ...
Johnson & Johnson on Wednesday reported some sales progress in the second quarter, following the completion of its US ...
Johnson & Johnson on Friday completed its acquisition of Shockwave Medical Inc, enhancing the company's cardiovascula ...
Johnson & Johnson on Wednesday proposed a USD6.48 billion settlement of tens of thousands of lawsuits which allege th ...
Johnson & Johnson on Tuesday upped its dividend for the first quarter and upgraded its guidance, after swinging to ne ...
Johnson & Johnson on Friday boosted its cardiovascular portfolio with the USD13.1 billion acquisition of Shockwave Me ...
- New Jersey-based pharmaceutical company - Announces the submission of a premarket approval application for the vari ...
- New Jersey-based pharmaceutical company - On Friday said that the oncological drug advisory committee of the US Foo ...
- New Brunswick, New Jersey-based pharmaceutical company - Subsidary Janssen Pharmaceuticals says the Committee for M ...
The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to ...
Johnson & Johnson on Tuesday said sales in its forth quarter and full-year rose, reflecting the "breadth and competit ...
- New Brunswick, New Jersey-based pharmaceutical company - US Food & Drug Administration grants full approval for Bal ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約